SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories reports consolidated net loss of Rs 492.44 crore in Q4

26 Feb 2013 Evaluate

Ranbaxy Laboratories has reported results for fourth quarter and year ended December 31, 2012.

The company has reported a net loss of Rs 616.09 crore for the quarter ended December 31, 2012 as compared to a net loss of Rs 2710.32 crore for the same quarter in the previous year. Total income of the company has decreased by 61.61% at Rs 1508.63 crore for quarter under review as compared to Rs 3930.35 crore for the quarter ended December 31, 2011.

On consolidated basis, the company has reported a net loss of Rs 492.44 crore for the quarter ended December 31, 2012 as compared to a net loss of Rs 2982.76 crore for the same quarter in the previous year. Total income of the company has decreased by 27.95% at Rs 2787.88 crore for quarter under review as compared to Rs 3869.38 crore for the quarter ended December 31, 2011.

For the fiscal 2012, the company has reported a net loss of Rs 162.33 crore for the year ended December 31, 2012 as compared to a net loss of Rs 3052.04 crore for the same in the previous year. Total income from operations went down by 16.38% to Rs 6543.14 crore from Rs 7825.19 crore in last year.

For the entire fiscal, on consolidated basis the company has reported a net profit of Rs 922.76 crore for the year ended December 31, 2012 as compared to a net loss of Rs 2899.72 crore for the same in the previous year. Total consolidated income from operations went up by 22.74% to Rs 12732.89 crore from Rs 10373.92 crore in last year.

Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×